chr3:46370946:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr3:46,412,437-46,417,697 |
hg38 | chr3:46,370,946-46,376,206 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.011 | Cardiovascular Diseases | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | Carotid Artery Diseases | NA | GAD | Detail | |
0.005 | carotid stenosis | NA | BeFree,GAD | Detail | |
0.005 | celiac disease | NA | GAD | Detail | |
<0.001 | CNS disorder | NA | BeFree | Detail | |
0.085 | brain ischemia | NA | GAD,RGD | Detail | |
0.003 | Transient ischemic attack | NA | BeFree,GAD | Detail | |
<0.001 | Malignant tumor of cervix | CCR5 expression is elevated in cervical cancer cells and is up-regulated by semi... | BeFree | 25103627 | Detail |
0.005 | Chagas Cardiomyopathy | NA | BeFree,GAD | Detail | |
0.007 | Chlamydia Infections | NA | BeFree,GAD | Detail | |
<0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
0.009 | Cholangitis, Sclerosing | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | chondrosarcoma | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
0.002 | Chromosome Deletion | NA | GAD | Detail | |
0.001 | ulcerative colitis | NA | BeFree | Detail | |
0.001 | colorectal carcinoma | We demonstrate that stronger secretion of CXCL10 (CXCR3 ligand) and CCL5 (CCR5 l... | BeFree | 25671296 | Detail |
0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
0.003 | coronary aneurysm | NA | BeFree,GAD | Detail | |
0.006 | Coronary Arteriosclerosis | NA | BeFree,GAD | Detail | |
0.009 | Coronary heart disease | NA | BeFree,GAD,LHGDN | Detail | |
0.006 | Crohn Disease | NA | BeFree,GAD | Detail | |
0.002 | Cross Infection | NA | GAD | Detail | |
0.003 | cryptosporidiosis | NA | BeFree,GAD | Detail | |
<0.001 | cystic fibrosis | Here, we report generation of cystic fibrosis (CF) and Gaucher's disease (GD) hi... | BeFree | 25245091 | Detail |
0.003 | Cytomegalovirus Infections | Incidence and dynamics of active cytomegalovirus infection in allogeneic stem ce... | BeFree,GAD | 25132583 | Detail |
<0.001 | Presenile dementia | NA | BeFree | Detail | |
<0.001 | Dengue Fever | Dengue virus requires the CC-chemokine receptor CCR5 for replication and infecti... | BeFree | 25939314 | Detail |
0.120 | Dermatitis, Atopic | NA | CTD_human | Detail | |
<0.001 | Diabetes | The CCR5 59029G>A and ELMO1 (+9170 G>A) loci are more frequent, and the SLC12A3 ... | BeFree | 24433479 | Detail |
<0.001 | diabetes mellitus | The CCR5 59029G>A and ELMO1 (+9170 G>A) loci are more frequent, and the SLC12A3 ... | BeFree | 24433479 | Detail |
0.102 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD,RGD | Detail | |
0.097 | Diabetes Mellitus, Non-Insulin-Dependent | Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with suscepti... | BeFree,GAD,RGD | 24433479 | Detail |
<0.001 | Down syndrome | A set of 17 differentially expressed genes, not located on chromosome 21 (HSA21)... | BeFree | 25222269 | Detail |
<0.001 | Dry Eye Syndromes | NA | BeFree | Detail | |
0.002 | Embolism | NA | GAD | Detail | |
0.004 | encephalitis | NA | BeFree,LHGDN | Detail | |
0.003 | tick-borne encephalitis | Independently of age, nonfunctional CCR5Δ32 mutation is a significant risk facto... | BeFree,GAD | 25226020 | Detail |
0.081 | Experimental Autoimmune Encephalomyelitis | NA | BeFree,RGD | Detail | |
<0.001 | endometriosis | NA | BeFree | Detail | |
0.002 | erythema nodosum | NA | GAD | Detail | |
0.080 | Fever | NA | RGD | Detail | |
<0.001 | Gaucher disease | Subsequent excision of the donor cassette was done by treating CCR5-modified CF ... | BeFree | 25245091 | Detail |
0.002 | Female Genital Diseases | NA | GAD | Detail | |
<0.001 | Gingival Diseases | NA | BeFree | Detail | |
<0.001 | glioblastoma | NA | BeFree | Detail | |
<0.001 | Glioma | NA | BeFree | Detail | |
0.131 | IgA glomerulonephritis | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.013 | Graft-vs-Host Disease | Several recent clinical trials were all based on previously reported findings fr... | BeFree,GAD,LHGDN | 25532439 | Detail |
<0.001 | Graves Disease | NA | BeFree | Detail | |
<0.001 | Heart failure | NA | BeFree | Detail | |
<0.001 | congestive heart failure | NA | BeFree | Detail | |
0.010 | Hemophilia A | NA | BeFree,GAD | Detail | |
0.017 | hepatitis B | We will provide a rigorous review of the Bayesian variable partition model and t... | BeFree,GAD,LHGDN | 25387976 | Detail |
0.159 | hepatitis C | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.001 | Herpes Simplex Infections | Enhanced HIV-1 replication was associated with increased CD4, CCR5, and CD38 tra... | BeFree | 24496317 | Detail |
0.003 | Herpes zoster disease | NA | BeFree,GAD | Detail | |
0.185 | HIV Infections | Coreceptor tropism was completely concordant in paired pre-treatment RNA and DNA... | BeFree,GAD,LHGDN | 24155059 | Detail |
0.185 | HIV Infections | HIV-1 uses the coreceptors CCR5 and/or CXCR4 for cell entry. | BeFree,GAD,LHGDN | 24205895 | Detail |
0.185 | HIV Infections | Enhanced HIV-1 replication was associated with increased CD4, CCR5, and CD38 tra... | BeFree,GAD,LHGDN | 24496317 | Detail |
0.185 | HIV Infections | The CX3CR1 A allele and lower genetic scores may restrict the switch of HIV-1 tr... | BeFree,GAD,LHGDN | 24750723 | Detail |
0.185 | HIV Infections | We investigated the impact of FGS on HIV target cell density and expression of t... | BeFree,GAD,LHGDN | 24896815 | Detail |
0.185 | HIV Infections | HIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep se... | BeFree,GAD,LHGDN | 25032817 | Detail |
0.185 | HIV Infections | When pDC were depleted prior to HIV-1 infection, the induction of IFN-I and inte... | BeFree,GAD,LHGDN | 25077616 | Detail |
0.185 | HIV Infections | A 32-nucleotide deletion within the CCR5 reading frame is associated with decrea... | BeFree,GAD,LHGDN | 25172974 | Detail |
0.185 | HIV Infections | Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in ... | BeFree,GAD,LHGDN | 25227930 | Detail |
0.185 | HIV Infections | The role of CCR5 in HIV infection led to the development of specific and potent ... | BeFree,GAD,LHGDN | 25256399 | Detail |
0.185 | HIV Infections | This high prevalence of X4 virus might compromise the use of CCR5 inhibitors, cu... | BeFree,GAD,LHGDN | 25265081 | Detail |
0.185 | HIV Infections | We illustrate our approach with an analysis of the effect of the CCR5Δ32 mutatio... | BeFree,GAD,LHGDN | 25270736 | Detail |
0.185 | HIV Infections | Furthermore, a mutated virus that is capable of using both CCR5 and CXCR4 as ent... | BeFree,GAD,LHGDN | 25330146 | Detail |
0.185 | HIV Infections | We will provide a rigorous review of the Bayesian variable partition model and t... | BeFree,GAD,LHGDN | 25387976 | Detail |
0.185 | HIV Infections | Replication competent recombinant viruses incorporating the HIV RNA+/Ab- as comp... | BeFree,GAD,LHGDN | 25430652 | Detail |
0.185 | HIV Infections | CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RN... | BeFree,GAD,LHGDN | 25541967 | Detail |
0.185 | HIV Infections | Genotyping of CCR5 gene, CCR2b and SDF1 variants related to HIV-1 infection in G... | BeFree,GAD,LHGDN | 25592723 | Detail |
0.185 | HIV Infections | CCR5 is a main cc-chemokine co-receptor that facilitates HIV-1 entry to macropha... | BeFree,GAD,LHGDN | 25613565 | Detail |
0.185 | HIV Infections | A deletion of 32bp (CCR5Δ32) in the CCR5 gene seems to protect against HIV-1, S.... | BeFree,GAD,LHGDN | 25638273 | Detail |
0.185 | HIV Infections | Studies of individuals who were highly exposed but seronegative (HESN) for HIV i... | BeFree,GAD,LHGDN | 25703062 | Detail |
0.185 | HIV Infections | The PhenoSeq platform will inform the appropriate use of maraviroc and future CC... | BeFree,GAD,LHGDN | 25712827 | Detail |
0.185 | HIV Infections | Viremic control and viral coreceptor usage in two HIV-1-infected persons homozyg... | BeFree,GAD,LHGDN | 25730507 | Detail |
0.185 | HIV Infections | The MIP-1α, MIP-1β, and RANTES chemokines are natural ligands of CCR5 and are kn... | BeFree,GAD,LHGDN | 25740989 | Detail |
0.185 | HIV Infections | However, the causes of resistance to HIV-1 infection in cases other than those w... | BeFree,GAD,LHGDN | 25746435 | Detail |
0.185 | HIV Infections | Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorp... | BeFree,GAD,LHGDN | 25797607 | Detail |
0.185 | HIV Infections | Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhanc... | BeFree,GAD,LHGDN | 25840914 | Detail |
0.185 | HIV Infections | Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 us... | BeFree,GAD,LHGDN | 25854553 | Detail |
0.185 | HIV Infections | Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers... | BeFree,GAD,LHGDN | 25903342 | Detail |
0.185 | HIV Infections | This study focuses on trafficking of CCR5, a GPCR chemokine receptor and the pri... | BeFree,GAD,LHGDN | 25923671 | Detail |
0.185 | HIV Infections | mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient... | BeFree,GAD,LHGDN | 25964300 | Detail |
0.185 | HIV Infections | The presence of CCR5-tropic variants in more than 85 % of our cohort of antiretr... | BeFree,GAD,LHGDN | 25966986 | Detail |
0.185 | HIV Infections | An impact of host genetic variation on HIV-1 susceptibility was identified early... | BeFree,GAD,LHGDN | 25988890 | Detail |
0.185 | HIV Infections | Over-expression of NHERF1 affects the ligands or HIV-1 gp120-induced CCR5 intern... | BeFree,GAD,LHGDN | 26018859 | Detail |
0.185 | HIV Infections | HIV-1 Nef, a key factor for viral pathogenesis, downregulates functionally impor... | BeFree,GAD,LHGDN | 26178998 | Detail |
0.185 | HIV Infections | The entry inhibitor drug maraviroc makes the cell coreceptor CCR5 unavailable fo... | BeFree,GAD,LHGDN | 26339063 | Detail |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
0.080 | Hyperalgesia | NA | RGD | Detail | |
0.003 | Hyperlipidemia | NA | BeFree,LHGDN | Detail | |
0.002 | Delayed Hypersensitivity | NA | GAD | Detail | |
0.002 | Immediate hypersensitivity | NA | GAD | Detail | |
0.085 | Hypertensive disease | NA | BeFree,GAD,RGD | Detail | |
0.002 | Hypertension, Portal | NA | GAD | Detail | |
0.001 | Immunologic Deficiency Syndromes | We show that ex vivo SIV infection of lymphocytes from CCR5 wild-type SM is medi... | BeFree | 26109719 | Detail |
0.002 | Female infertility | NA | GAD | Detail | |
0.104 | Inflammation | NA | GAD,RGD | Detail | |
0.007 | Inflammatory Bowel Diseases | NA | BeFree,GAD | Detail | |
0.001 | influenza | The CCR5Δ32 allele was not found to be associated with the risk of H1N1pdm09 inf... | BeFree | 25100510 | Detail |
0.001 | influenza | CCR5 deficiency predisposes to fatal outcome in influenza virus infection. | BeFree | 25918237 | Detail |
0.002 | ischemia | NA | GAD | Detail | |
<0.001 | arthropathy | NA | BeFree | Detail | |
0.002 | Kidney Diseases | Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with suscepti... | BeFree | 24433479 | Detail |
0.096 | Kidney Failure, Chronic | NA | BeFree,GAD,LHGDN,RGD | Detail | |
<0.001 | acute kidney tubular necrosis | NA | BeFree | Detail | |
0.002 | Laryngeal neoplasm | NA | GAD | Detail | |
<0.001 | leishmaniasis | NA | BeFree | Detail | |
0.002 | Leishmaniasis, Cutaneous | NA | GAD | Detail | |
0.003 | leukemia | NA | BeFree,LHGDN | Detail | |
<0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
0.002 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | GAD | Detail | |
0.003 | liver cirrhosis | NA | BeFree,GAD | Detail | |
0.002 | Biliary cirrhosis | NA | GAD | Detail | |
0.004 | Liver diseases | NA | BeFree,LHGDN | Detail | |
0.002 | Liver neoplasms | NA | GAD | Detail | |
0.003 | Lung diseases | NA | BeFree,LHGDN | Detail | |
0.006 | Chronic Obstructive Airway Disease | NA | BeFree,GAD,LHGDN | Detail | |
0.004 | Lupus Erythematosus, Systemic | This meta-analysis demonstrates that the CCR5-Δ32 polymorphism is associated wit... | BeFree,GAD | 24599359 | Detail |
0.009 | lupus nephritis | Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large ca... | BeFree,GAD,LHGDN | 24720467 | Detail |
0.003 | lymphocytic choriomeningitis | NA | LHGDN | Detail | |
0.003 | lymphoma | NA | BeFree,GAD | Detail | |
<0.001 | Lymphoma, Follicular | NA | BeFree | Detail | |
<0.001 | malaria | NA | BeFree | Detail | |
0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
<0.001 | measles | NA | BeFree | Detail | |
0.005 | melanoma | NA | GAD,LHGDN | Detail | |
0.003 | meningoencephalitis | NA | BeFree,GAD | Detail | |
0.002 | mitral valve stenosis | NA | BeFree | Detail | |
<0.001 | Mouth Neoplasms | NA | BeFree | Detail | |
0.011 | Mucocutaneous Lymph Node Syndrome | However, the overall OR for the CCR5-Δ32 allele was significantly higher in Kawa... | BeFree,GAD,LHGDN | 24599359 | Detail |
0.003 | multiple myeloma | NA | BeFree,LHGDN | Detail | |
0.054 | multiple sclerosis | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Mycobacterium avium-intracellulare Infection | NA | BeFree,GAD | Detail | |
<0.001 | Mycoses | NA | BeFree | Detail | |
0.014 | myocardial infarction | NA | BeFree,GAD,LHGDN | Detail | |
0.080 | Myocardial Reperfusion Injury | NA | RGD | Detail | |
0.003 | myositis | NA | BeFree,LHGDN | Detail | |
0.002 | Neoplasm Metastasis | The data reviewed here includes basic and translational studies that support the... | BeFree | 25256399 | Detail |
0.002 | Neoplasm Metastasis | We demonstrate that stronger secretion of CXCL10 (CXCR3 ligand) and CCL5 (CCR5 l... | BeFree | 25671296 | Detail |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.120 | nephritis | NA | CTD_human | Detail | |
<0.001 | Nephritis, Interstitial | NA | BeFree | Detail | |
0.002 | nephrotic syndrome | NA | GAD | Detail | |
<0.001 | nervous system disorder | NA | BeFree | Detail | |
<0.001 | neuroblastoma | NA | BeFree | Detail | |
<0.001 | obesity | NA | BeFree | Detail | |
0.002 | Occupational Diseases | NA | GAD | Detail | |
<0.001 | Opportunistic Infections | NA | BeFree | Detail | |
0.003 | optic neuritis | NA | LHGDN | Detail | |
0.080 | orchitis | NA | RGD | Detail | |
<0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
<0.001 | osteomyelitis | The CCR5Δ32 could be associated with protection against osteomyelitis caused by ... | BeFree | 25638273 | Detail |
<0.001 | osteosarcoma | CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angioge... | BeFree | 25330803 | Detail |
<0.001 | Pancreatic Neoplasm | NA | BeFree | Detail | |
<0.001 | Periodontal Diseases | NA | BeFree | Detail | |
0.003 | periodontitis | NA | BeFree,GAD | Detail | |
0.005 | plague | NA | GAD | Detail | |
0.003 | polymyalgia rheumatica | NA | BeFree,GAD | Detail | |
0.002 | Postoperative Complications | NA | GAD | Detail | |
0.007 | Pregnancy Complications, Infectious | NA | GAD | Detail | |
0.005 | Prostatic Neoplasms | NA | LHGDN | Detail | |
<0.001 | psoriasis | NA | BeFree | Detail | |
<0.001 | pulmonary edema | NA | BeFree | Detail | |
0.001 | kidney failure | NA | BeFree | Detail | |
0.005 | Respiratory Syncytial Virus Infections | NA | GAD | Detail | |
<0.001 | retinal detachment | NA | BeFree | Detail | |
0.002 | Rheumatism | NA | GAD | Detail | |
0.009 | sarcoidosis | NA | BeFree,GAD,LHGDN | Detail | |
0.008 | Sarcoidosis, Pulmonary | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | schizophrenia | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Sexually Transmitted Diseases | NA | BeFree | Detail | |
0.002 | Skin Neoplasms | NA | GAD | Detail | |
<0.001 | smallpox | NA | BeFree | Detail | |
0.080 | status epilepticus | NA | RGD | Detail | |
0.005 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
0.005 | Substance Abuse, Intravenous | NA | GAD | Detail | |
0.003 | Superinfection | HIV-1 Nef downregulates the viral entry receptor CD4 as well as the coreceptors ... | BeFree,LHGDN | 26178998 | Detail |
<0.001 | synovitis | NA | BeFree | Detail | |
<0.001 | syphilis | NA | BeFree | Detail | |
<0.001 | Giant Cell Arteritis | NA | BeFree | Detail | |
<0.001 | tetanus | NA | BeFree | Detail | |
0.002 | Thyroid Neoplasm | NA | GAD | Detail | |
0.003 | toxoplasmosis | NA | BeFree,GAD | Detail | |
0.002 | trachoma | NA | GAD | Detail | |
0.009 | Chagas disease | Nine SNPs of CCR5 and CCR2 were typified to confirm the association previously f... | BeFree,GAD,LHGDN | 25312802 | Detail |
0.001 | tuberculosis | NA | BeFree | Detail | |
0.001 | Tuberculosis, Pulmonary | NA | BeFree | Detail | |
0.082 | uveitis | NA | GAD,RGD | Detail | |
0.080 | anterior uveitis | NA | RGD | Detail | |
<0.001 | Vascular Diseases | NA | BeFree | Detail | |
0.003 | vasculitis | NA | BeFree,LHGDN | Detail | |
0.010 | Viremia | While this CCR5 antagonist has initially been used in salvage therapy, its excel... | BeFree,GAD,LHGDN | 24155059 | Detail |
0.004 | Virus Diseases | CCR5 deficiency predisposes to fatal outcome in influenza virus infection. | BeFree | 25918237 | Detail |
0.004 | Virus Diseases | These data bring new insights on the association between viral infections and th... | BeFree | 25939314 | Detail |
0.003 | vitiligo | NA | BeFree,GAD | Detail | |
0.125 | West Nile fever | NA | CTD_human,GAD | Detail | |
<0.001 | yellow fever | NA | BeFree | Detail | |
0.002 | diffuse large B-cell lymphoma | NA | GAD | Detail | |
<0.001 | Lymphoma, AIDS-Related | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
0.005 | Bronchial Hyperreactivity | NA | GAD | Detail | |
0.003 | Arthritis, Reactive | NA | BeFree,GAD | Detail | |
<0.001 | acute leukemia | The aim of this study was to investigate the mannose-binding lectin 2 (MBL-2), i... | BeFree | 24819208 | Detail |
0.003 | Epstein-Barr Virus Infections | NA | BeFree,GAD | Detail | |
0.002 | Left Ventricular Hypertrophy | NA | GAD | Detail | |
<0.001 | Genital ulceration | NA | BeFree | Detail | |
<0.001 | Active tuberculosis | NA | BeFree | Detail | |
<0.001 | Primary Sj�gren's syndrome | This meta-analysis demonstrates that the CCR5-Δ32 polymorphism is associated wit... | BeFree | 24599359 | Detail |
<0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
<0.001 | Joint swelling | NA | BeFree | Detail | |
<0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Systemic candidiasis | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of bone | CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed... | BeFree | 25452256 | Detail |
<0.001 | allergic asthma | NA | BeFree | Detail | |
<0.001 | Infections specific to perinatal period | NA | BeFree | Detail | |
0.080 | Dermatitis, Allergic Contact | NA | RGD | Detail | |
0.002 | Aneurysm, Ruptured | NA | GAD | Detail | |
0.008 | Aortic Aneurysm, Abdominal | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
0.004 | Lichen Planus, Oral | NA | BeFree,LHGDN | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
<0.001 | Chronic berylliosis | NA | BeFree | Detail | |
<0.001 | Morning stiffness (>1 hour) | NA | BeFree | Detail | |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | pediatric AIDS | NA | BeFree | Detail | |
0.002 | Renal transplant rejection | NA | GAD | Detail | |
0.002 | Malignant neoplasm of lung | NA | GAD | Detail | |
0.003 | Neoplasm, Residual | NA | BeFree,GAD | Detail | |
<0.001 | Mucosa-Associated Lymphoid Tissue Lymphoma | NA | BeFree | Detail | |
0.005 | Disease Progression | NA | GAD,LHGDN | Detail | |
<0.001 | Parasitemia | NA | BeFree | Detail | |
<0.001 | Ichthyosis linearis circumflexa | NA | BeFree | Detail | |
<0.001 | Vesicular Stomatitis | NA | BeFree | Detail | |
<0.001 | Coinfection | NA | BeFree | Detail | |
<0.001 | Metastatic melanoma | NA | BeFree | Detail | |
0.003 | Cancer of Head and Neck | NA | BeFree,GAD | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | bubonic plague | NA | BeFree | Detail | |
0.006 | cervix carcinoma | CCR5 expression is elevated in cervical cancer cells and is up-regulated by semi... | BeFree,GAD | 25103627 | Detail |
0.002 | Restenosis | NA | GAD | Detail | |
<0.001 | Superficial ulcer | NA | BeFree | Detail | |
<0.001 | Rocio virus encephalitis | NA | BeFree | Detail | |
0.002 | Human immunodeficiency virus leukoencephalopathy | NA | GAD | Detail | |
<0.001 | Chronic liver disease | NA | BeFree | Detail | |
<0.001 | Asymptomatic human immunodeficiency virus infection | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of pancreas | NA | BeFree,GAD | Detail | |
<0.001 | Disseminated Malignant Neoplasm | NA | BeFree | Detail | |
<0.001 | Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
<0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
0.005 | Hematologic Neoplasms | NA | GAD | Detail | |
<0.001 | Idiopathic crescentic glomerulonephritis | NA | BeFree | Detail | |
<0.001 | Infective vaginitis | NA | BeFree | Detail | |
<0.001 | neuropathy | NA | BeFree | Detail | |
0.003 | tick-borne encephalitis | A possible association between predisposition to TBE in a Russian population and... | BeFree | 23721942 | Detail |
0.003 | hiv-infection/aids | Autologous Hematopoietic Stem Cells transplantation and genetic modification of ... | BeFree | 25613565 | Detail |
<0.001 | dementia | NA | BeFree | Detail | |
<0.001 | Granulomatosis | NA | BeFree | Detail | |
<0.001 | Metabolic syndrome X | NA | BeFree | Detail | |
0.005 | Hepatitis B, Chronic | NA | GAD | Detail | |
0.019 | Hepatitis C, Chronic | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | primary sclerosing cholangitis | NA | BeFree | Detail | |
<0.001 | Osteosarcoma of bone | CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angioge... | BeFree | 25330803 | Detail |
<0.001 | Biliary stricture | NA | BeFree | Detail | |
0.002 | prostate carcinoma | NA | BeFree | Detail | |
0.002 | breast carcinoma | Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with bre... | BeFree | 25171476 | Detail |
0.002 | breast carcinoma | The potential to target CCL5/CCR5 in breast cancer. | BeFree | 25256399 | Detail |
<0.001 | Terminal illness | NA | BeFree | Detail | |
0.002 | Hemophilia, NOS | NA | BeFree | Detail | |
0.002 | Pregnancy loss | NA | GAD | Detail | |
<0.001 | colon carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | AIDS defining illness | NA | BeFree | Detail | |
<0.001 | infertility tubal factor | NA | BeFree | Detail | |
<0.001 | lung disease granulomatous | NA | BeFree | Detail | |
0.080 | Hypoxia-Ischemia, Brain | NA | RGD | Detail | |
<0.001 | Acute GVH disease | NA | BeFree | Detail | |
<0.001 | Cardiomyopathies | SNP/haplotype associations of CCR2 and CCR5 genes with severity of chagasic card... | BeFree | 25312802 | Detail |
<0.001 | Metastatic Prostate Carcinoma | CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed... | BeFree | 25452256 | Detail |
0.002 | Acute coronary syndrome | NA | GAD | Detail | |
0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
0.002 | coronary restenosis | NA | GAD | Detail | |
0.080 | Arthritis, Experimental | NA | RGD | Detail | |
0.002 | West Nile viral infection | NA | BeFree | Detail | |
0.012 | HIV disease progression | NA | GAD | Detail | |
<0.001 | Primary HIV infection | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
0.002 | Systemic arterial pressure | NA | GAD | Detail | |
<0.001 | Inflammatory disorder | Recent evidence has demonstrated the role of CCR5Δ32 in a variety of human disea... | BeFree | 25172974 | Detail |
<0.001 | Aggressive natural killer-cell leukemia | NA | BeFree | Detail | |
<0.001 | Peripheral arterial occlusive disease | NA | BeFree | Detail | |
<0.001 | Pediatric human immunodeficiency virus infection | NA | BeFree | Detail | |
0.003 | mucocutaneous leishmaniasis | NA | BeFree,GAD | Detail | |
0.006 | Mammary Neoplasms | Recent evidence has demonstrated the implication of CC chemokine ligand 5 (CCL5)... | BeFree,GAD,LHGDN | 25171476 | Detail |
<0.001 | Neuropathogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angioge... | BeFree | 25330803 | Detail |
0.001 | colorectal cancer | We demonstrate that stronger secretion of CXCL10 (CXCR3 ligand) and CCL5 (CCR5 l... | BeFree | 25671296 | Detail |
0.002 | Sjogren's syndrome | NA | GAD | Detail | |
0.003 | Pneumocystis jiroveci pneumonia | NA | BeFree,GAD | Detail | |
<0.001 | Ocular surface disease | NA | BeFree | Detail | |
<0.001 | Non-Malignant Ascites Adverse Event | NA | BeFree | Detail | |
0.003 | Renal Insufficiency | NA | BeFree,LHGDN | Detail | |
<0.001 | Upper urinary tract infection | NA | BeFree | Detail | |
<0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
0.002 | Venous thromboembolism | NA | GAD | Detail | |
0.088 | coronary artery disease | NA | BeFree,GAD,RGD | Detail | |
0.003 | liver carcinoma | NA | BeFree,GAD | Detail | |
0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
0.002 | HIV-1 infection | NA | GAD | Detail | |
0.120 | Acute kidney injury | NA | CTD_human | Detail | |
0.120 | DIABETES MELLITUS, INSULIN-DEPENDENT, 22 (disorder) | NA | CTD_human | Detail | |
0.002 | Chronic ulcerative colitis | NA | GAD | Detail | |
<0.001 | Pulmonary arterial hypertension | NA | BeFree | Detail | |
0.009 | Juvenile arthritis | NA | BeFree,GAD | Detail | |
0.002 | granulomatosis with polyangiitis | NA | GAD | Detail | |
0.054 | Infection | NA | LHGDN | Detail | |
0.002 | juvenile rheumatoid arthritis | NA | BeFree | Detail | |
<0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | NA | BeFree | Detail | |
<0.001 | Flaviviral diseases | NA | BeFree | Detail | |
0.045 | acquired immunodeficiency syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | adenocarcinoma | NA | LHGDN | Detail | |
<0.001 | AIDS Dementia Complex | NA | BeFree | Detail | |
0.089 | Alzheimer's disease | NA | GAD,RGD | Detail | |
0.005 | Anemia, Sickle Cell | NA | BeFree,GAD | Detail | |
0.002 | aortic valve stenosis | NA | GAD | Detail | |
0.008 | Arterial Occlusive Diseases | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | arteriosclerosis | NA | BeFree | Detail | |
0.004 | arthritis | NA | BeFree,GAD | Detail | |
0.003 | Arthritis, Psoriatic | NA | BeFree,GAD | Detail | |
0.032 | rheumatoid arthritis | In addition to the strong association between alleles of the HLA-DRB1*04 shared ... | BeFree,GAD,LHGDN | 25163740 | Detail |
0.032 | rheumatoid arthritis | CCL2, CCL4, c-Jun, c-Fos, and CCR5 may play an important role in the recruitment... | BeFree,GAD,LHGDN | 26069140 | Detail |
0.039 | asthma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Astrocytoma | NA | BeFree | Detail | |
0.012 | atherosclerosis | NA | BeFree,GAD,LHGDN | Detail | |
0.006 | Behcet Syndrome | Association of CCR5Δ32 and Behçet's disease: new data from a case-control study ... | BeFree,GAD,LHGDN | 26393284 | Detail |
0.002 | berylliosis | NA | GAD | Detail | |
0.002 | Biliary Tract Diseases | NA | GAD | Detail | |
0.003 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
<0.001 | Bone Diseases | NA | BeFree | Detail | |
0.002 | Brain Neoplasms | NA | GAD | Detail | |
0.004 | Malignant neoplasm of breast | Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with bre... | BeFree,GAD | 25171476 | Detail |
0.004 | Malignant neoplasm of breast | The potential to target CCL5/CCR5 in breast cancer. | BeFree,GAD | 25256399 | Detail |
0.003 | bronchiolitis | NA | BeFree,LHGDN | Detail | |
0.002 | Bronchiolitis, Viral | NA | GAD | Detail | |
0.005 | brucellosis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Malignant tumor of colon | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We demonstrate that stronger secretion of CXCL10 (CXCR3 ligand) and CCL5 (CCR5 ligand) and infiltrat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we report generation of cystic fibrosis (CF) and Gaucher's disease (GD) hiPSCs respectively fr... | DisGeNET | Detail |
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patien... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development. | DisGeNET | Detail |
NA | DisGeNET | Detail |
The CCR5 59029G>A and ELMO1 (+9170 G>A) loci are more frequent, and the SLC12A3 34372 AA genotype is... | DisGeNET | Detail |
The CCR5 59029G>A and ELMO1 (+9170 G>A) loci are more frequent, and the SLC12A3 34372 AA genotype is... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney dis... | DisGeNET | Detail |
A set of 17 differentially expressed genes, not located on chromosome 21 (HSA21), involved in immune... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Independently of age, nonfunctional CCR5Δ32 mutation is a significant risk factor for development of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Subsequent excision of the donor cassette was done by treating CCR5-modified CF and GD hiPSCs with C... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Several recent clinical trials were all based on previously reported findings from the mouse model o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We will provide a rigorous review of the Bayesian variable partition model and the recursive model s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Enhanced HIV-1 replication was associated with increased CD4, CCR5, and CD38 transcription (P<0.05) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Coreceptor tropism was completely concordant in paired pre-treatment RNA and DNA, with 26.2% of HIV-... | DisGeNET | Detail |
HIV-1 uses the coreceptors CCR5 and/or CXCR4 for cell entry. | DisGeNET | Detail |
Enhanced HIV-1 replication was associated with increased CD4, CCR5, and CD38 transcription (P<0.05) ... | DisGeNET | Detail |
The CX3CR1 A allele and lower genetic scores may restrict the switch of HIV-1 tropism from R5 to X4. | DisGeNET | Detail |
We investigated the impact of FGS on HIV target cell density and expression of the HIV co-receptor C... | DisGeNET | Detail |
HIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR... | DisGeNET | Detail |
When pDC were depleted prior to HIV-1 infection, the induction of IFN-I and interferon-stimulated ge... | DisGeNET | Detail |
A 32-nucleotide deletion within the CCR5 reading frame is associated with decreased susceptibility t... | DisGeNET | Detail |
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing mono... | DisGeNET | Detail |
The role of CCR5 in HIV infection led to the development of specific and potent CCR5 antagonists. | DisGeNET | Detail |
This high prevalence of X4 virus might compromise the use of CCR5 inhibitors, currently mostly consi... | DisGeNET | Detail |
We illustrate our approach with an analysis of the effect of the CCR5Δ32 mutation on HIV acquisition... | DisGeNET | Detail |
Furthermore, a mutated virus that is capable of using both CCR5 and CXCR4 as entry coreceptor is spe... | DisGeNET | Detail |
We will provide a rigorous review of the Bayesian variable partition model and the recursive model s... | DisGeNET | Detail |
Replication competent recombinant viruses incorporating the HIV RNA+/Ab- as compared to the chronic ... | DisGeNET | Detail |
CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resi... | DisGeNET | Detail |
Genotyping of CCR5 gene, CCR2b and SDF1 variants related to HIV-1 infection in Gabonese subjects. | DisGeNET | Detail |
CCR5 is a main cc-chemokine co-receptor that facilitates HIV-1 entry to macrophage and CD4(+) T cell... | DisGeNET | Detail |
A deletion of 32bp (CCR5Δ32) in the CCR5 gene seems to protect against HIV-1, S.aureus and other inf... | DisGeNET | Detail |
Studies of individuals who were highly exposed but seronegative (HESN) for HIV infection led to the ... | DisGeNET | Detail |
The PhenoSeq platform will inform the appropriate use of maraviroc and future CCR5 blocking drugs in... | DisGeNET | Detail |
Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32. | DisGeNET | Detail |
The MIP-1α, MIP-1β, and RANTES chemokines are natural ligands of CCR5 and are known to interfere wit... | DisGeNET | Detail |
However, the causes of resistance to HIV-1 infection in cases other than those with a homozygous CCR... | DisGeNET | Detail |
Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 b... | DisGeNET | Detail |
Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression a... | DisGeNET | Detail |
Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-deliv... | DisGeNET | Detail |
Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Pers... | DisGeNET | Detail |
This study focuses on trafficking of CCR5, a GPCR chemokine receptor and the principal entry corecep... | DisGeNET | Detail |
mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-... | DisGeNET | Detail |
The presence of CCR5-tropic variants in more than 85 % of our cohort of antiretroviral-naïve blood d... | DisGeNET | Detail |
An impact of host genetic variation on HIV-1 susceptibility was identified early in the pandemic, wi... | DisGeNET | Detail |
Over-expression of NHERF1 affects the ligands or HIV-1 gp120-induced CCR5 internalization and HIV-1 ... | DisGeNET | Detail |
HIV-1 Nef, a key factor for viral pathogenesis, downregulates functionally important molecules from ... | DisGeNET | Detail |
The entry inhibitor drug maraviroc makes the cell coreceptor CCR5 unavailable for use by HIV-1 and i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We show that ex vivo SIV infection of lymphocytes from CCR5 wild-type SM is mediated by both CXCR6 a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The CCR5Δ32 allele was not found to be associated with the risk of H1N1pdm09 infection or with a sev... | DisGeNET | Detail |
CCR5 deficiency predisposes to fatal outcome in influenza virus infection. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney dis... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This meta-analysis demonstrates that the CCR5-Δ32 polymorphism is associated with KD, but does not f... | DisGeNET | Detail |
Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large case-control study and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, the overall OR for the CCR5-Δ32 allele was significantly higher in Kawasaki disease (KD; OR... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The data reviewed here includes basic and translational studies that support the use of such CCR5 an... | DisGeNET | Detail |
We demonstrate that stronger secretion of CXCL10 (CXCR3 ligand) and CCL5 (CCR5 ligand) and infiltrat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The CCR5Δ32 could be associated with protection against osteomyelitis caused by S. aureus, corrobora... | DisGeNET | Detail |
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HIV-1 Nef downregulates the viral entry receptor CD4 as well as the coreceptors CCR5 and CXCR4 from ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Nine SNPs of CCR5 and CCR2 were typified to confirm the association previously found with Chagas dis... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
While this CCR5 antagonist has initially been used in salvage therapy, its excellent safety profile ... | DisGeNET | Detail |
CCR5 deficiency predisposes to fatal outcome in influenza virus infection. | DisGeNET | Detail |
These data bring new insights on the association between viral infections and the chemokine receptor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the mannose-binding lectin 2 (MBL-2), interleukin (IL)-4, T... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This meta-analysis demonstrates that the CCR5-Δ32 polymorphism is associated with KD, but does not f... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A possible association between predisposition to TBE in a Russian population and two polymorphisms, ... | DisGeNET | Detail |
Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutan... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer. | DisGeNET | Detail |
The potential to target CCL5/CCR5 in breast cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
SNP/haplotype associations of CCR2 and CCR5 genes with severity of chagasic cardiomyopathy. | DisGeNET | Detail |
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recent evidence has demonstrated the role of CCR5Δ32 in a variety of human diseases: from infectious... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recent evidence has demonstrated the implication of CC chemokine ligand 5 (CCL5) and CC chemokine re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteo... | DisGeNET | Detail |
We demonstrate that stronger secretion of CXCL10 (CXCR3 ligand) and CCL5 (CCR5 ligand) and infiltrat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition to the strong association between alleles of the HLA-DRB1*04 shared epitope and both sub... | DisGeNET | Detail |
CCL2, CCL4, c-Jun, c-Fos, and CCR5 may play an important role in the recruitment of PB leukocytes in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of CCR5Δ32 and Behçet's disease: new data from a case-control study in the Spanish popul... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer. | DisGeNET | Detail |
The potential to target CCL5/CCR5 in breast cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386586050 dbSNP
- Genome
- hg38
- Position
- chr3:46,370,946-46,376,206
- Variant Type
- snv
Genome browser